Dysphagia CPD Module 2- Swallowing Difficulties and Epilepsy

Literature • Rosemont Pharmaceuticals

About the CPD course

The module considers how swallowing difficulties (dysphagia) can be associated with epilepsy and highlights some of the patient groups more likely to have epilepsy; who may be at risk. After working through the module; you should: Understand the impact of medication non-adherence in epileptic patients. Be able to identify key patient groups who are more likely to have epilepsy and experience swallowing difficulties. Be able to discuss why it is particularly important for epileptic patients to receive a licensed formulation. Understand the additional complexity that administering medication through enteral feeding tubes can have for epileptic patients.

CPD Provider

Rosemont Pharmaceuticals

View Profile

Send an enquiry

Full Name*

Email Address*

Contact Number*

Industry*

Your Enquiry*

By submitting this form, you consent to CPD sending you email regarding your application.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rosemont Pharmaceuticals

Rosemont are specialist manufacturers of oral liquid medicines, with over 50 years dedicated experience. We have an extensive portfolio of products across a range of therapeutic categories. New products are continually being developed at our state-of-the-art UK facilities, to further support patients with swallowing difficulties, and the healthcare professionals who care for them.